Matthew J. McQueen

Best Publications

• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

  Salim Yusuf;Steven Hawken;Stephanie Ôunpuu;Tony Dans

  16906
  Citations

• Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

  Martin J O'Donnell;Martin J O'Donnell;Denis Xavier;Lisheng Liu;Hongye Zhang

  4356
  Citations

• Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

  Eva Lonn;Salim Yusuf;J. Arnold;Janice Pogue

  2329
  Citations

• Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

  Martin J O'Donnell;Martin J O'Donnell;Siu Lim Chin;Sumathy Rangarajan;Denis Xavier

  2091
  Citations

• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

  Johannes F. E. Mann;Roland E Schmieder;Matthew McQueen;Leanne Dyal

  1991
  Citations

• Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

  Sonia S Anand;Salim Yusuf;Vladmir Vuksan;Sudarshan Devanesen

  1334
  Citations

• Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery

  P. J. Devereaux;M. T. Chan;P. Alonso-Coello

  1110
  Citations

• Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

  Matthew J McQueen;Steven Hawken;Xingyu Wang;Stephanie Ounpuu

  1076
  Citations

• Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

  Salim Yusuf;Sumathy Rangarajan;Koon Teo;Shofiqul Islam

  1050
  Citations

• Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events

  Andrew Mente;Sumathy Rangarajan;Matthew J. McQueen;Xingyu Wang

  972
  Citations

• Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes

  Fernando Botto;Pablo Alonso-Coello;Matthew T V Chan;Matthew T V Chan;Juan Carlos Villar

  921
  Citations

• Association of Urinary Sodium and Potassium Excretion with Blood Pressure

  Andrew Mente;Sumathy Rangarajan;Matthew J. McQueen;Paul Poirier

  920
  Citations

• A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk

  Allan D. Sniderman;Ken Williams;John H. Contois;Howard M. Monroe

  795
  Citations

• Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery.

  P. J. Devereaux;Bruce M. Biccard;Alben Sigamani;Denis Xavier

  726
  Citations

• Defining obesity cut points in a multiethnic population.

  Fahad Razak;Sonia S. Anand;Harry Shannon;Vladimir Vuksan

  688
  Citations

• Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events

  Martin J. O'Donnell;Salim Yusuf;Andrew Mente;Peggy Gao

  684
  Citations

• Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies

  Andrew Mente;Martin O'Donnell;Martin O'Donnell;Sumathy Sumathy Rangarajan;Gilles Dagenais

  508
  Citations

• Current Issues in Measurement and Reporting of Urinary Albumin Excretion

  W. Greg Miller;David E. Bruns;Glen L. Hortin;Sverre Sandberg

  457
  Citations

• The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.

  S. Yusuf;S. Mehta;S. Anand;A. Avezum

  420
  Citations

• Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability Additional Findings From the HOPE 2 Trial

  Gustavo Saposnik;Joel G. Ray;Patrick Sheridan;Matthew McQueen

  394
  Citations